LONDON — Pharma giant AstraZeneca says it has resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
“Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so,” the company says in a statement.
AstraZeneca announced on Wednesday it had “voluntarily paused” its trial of the vaccine, developed alongside Oxford University, after the volunteer developed an unexplained illness.
An independent committee was drafted to review safety, in what the company and the World Health Organization described as a routine step.
The committee “has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume”, AstraZeneca says.
AstraZeneca’s vaccine candidate is one of nine around the world currently in late-stage Phase 3 human trials.
— AFP
Animal lovers, this one's for you
In 1935, Rabbi Max Shorenstein left Denmark to pursue his lifelong dream: building a zoo in Tel Aviv and teaching children to love animals. The Tel Aviv Zoo became one of the city’s greatest attractions, but envy, greed, and corruption drove Shorenstein from the paradise he created.
The film 'There Are No Lions in Tel Aviv' is available to screen November 19-26 for members of our reader support group, The Times of Israel Community. Join the Community today to support our work and watch our DocuNation series of outstanding Israeli documentary films.
I want to watch
I want to watch
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this